BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33671923)

  • 1. Preparation and Bioevaluation of Novel
    Ruan Q; Gan Q; Zhang X; Fang S; Zhang J
    Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33671923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Bioevaluation of Novel Technetium-99m-Labeled Complexes with Norfloxacin HYNIC Derivatives for Bacterial Infection Imaging.
    Jiang Y; Fang S; Feng J; Ruan Q; Zhang J
    Mol Pharm; 2023 Jan; 20(1):630-640. PubMed ID: 36398935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of
    Gan Q; Song X; Zhang X; Zhang J
    Eur J Med Chem; 2020 Feb; 188():112032. PubMed ID: 31926467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of coligand variation on the in vivo characteristics of Tc-99m-labeled interleukin-8 in detection of infection.
    Rennen HJ; van Eerd JE; Oyen WJ; Corstens FH; Edwards DS; Boerman OC
    Bioconjug Chem; 2002; 13(2):370-7. PubMed ID: 11906276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
    Liu S; Hsieh WY; Jiang Y; Kim YS; Sreerama SG; Chen X; Jia B; Wang F
    Bioconjug Chem; 2007; 18(2):438-46. PubMed ID: 17341108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer.
    Shi J; Jia B; Liu Z; Yang Z; Yu Z; Chen K; Chen X; Liu S; Wang F
    Bioconjug Chem; 2008 Jun; 19(6):1170-8. PubMed ID: 18491928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
    Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR
    Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coligand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramer.
    Liu S; Kim YS; Hsieh WY; Gupta Sreerama S
    Nucl Med Biol; 2008 Jan; 35(1):111-21. PubMed ID: 18158950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer.
    Liu S; Hsieh WY; Kim YS; Mohammed SI
    Bioconjug Chem; 2005; 16(6):1580-8. PubMed ID: 16287258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties.
    Zhou Y; Kim YS; Lu X; Liu S
    Bioconjug Chem; 2012 Mar; 23(3):586-95. PubMed ID: 22369387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer.
    Yang X; Li G; Ruan C; Hu K; Tang G
    Bioconjug Chem; 2023 Nov; 34(11):2133-2143. PubMed ID: 37874952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.
    Wang L; Shi J; Kim YS; Zhai S; Jia B; Zhao H; Liu Z; Wang F; Chen X; Liu S
    Mol Pharm; 2009; 6(1):231-45. PubMed ID: 19067525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules.
    Ji S; Zhou Y; Shao G; Liu S
    Bioconjug Chem; 2013 Apr; 24(4):701-11. PubMed ID: 23521129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, radiolabeling and evaluation of [
    Dinmohammadi F; Erfani M; Shamsaei M; Shirmardi SP; Goudarzi M
    Bioorg Chem; 2023 Jan; 130():106237. PubMed ID: 36402025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc-labeled RGD-BBN peptide for small-animal SPECT/CT of lung carcinoma.
    Liu Z; Huang J; Dong C; Cui L; Jin X; Jia B; Zhu Z; Li F; Wang F
    Mol Pharm; 2012 May; 9(5):1409-17. PubMed ID: 22452411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational Design and Comparison of Novel
    Meng L; Fang J; Zhang J; Li H; Xia D; Zhuang R; Chen H; Huang J; Li Y; Zhang X; Guo Z
    J Med Chem; 2024 May; 67(10):8460-8472. PubMed ID: 38717104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tricine co-ligand improved the efficacy of
    Shaghaghi Z; Abedi SM; Hosseinimehr SJ
    Biomed Pharmacother; 2018 Aug; 104():325-331. PubMed ID: 29775901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging.
    Ji S; Czerwinski A; Zhou Y; Shao G; Valenzuela F; SowiƄski P; Chauhan S; Pennington M; Liu S
    Mol Pharm; 2013 Sep; 10(9):3304-14. PubMed ID: 23875883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel
    Ruan Q; Zhang X; Lin X; Duan X; Zhang J
    Medchemcomm; 2018 Jun; 9(6):988-994. PubMed ID: 30108988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.